{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:40:27Z","timestamp":1783698027098,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI146009"],"award-info":[{"award-number":["R01AI146009"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013187","name":"Randy Shaver Cancer Research and Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000885","name":"Children's Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002086","name":"Fanconi Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1UM1TR004405"],"award-info":[{"award-number":["1UM1TR004405"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1T32TR004385"],"award-info":[{"award-number":["1T32TR004385"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1T32TR004376"],"award-info":[{"award-number":["1T32TR004376"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ymthe.2024.09.033","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T03:31:43Z","timestamp":1728012703000},"page":"3865-3878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Engineering memory T\u00a0cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5174-1314","authenticated-orcid":false,"given":"Evan W.","family":"Kleinboehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanut","family":"Laoharawee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Slipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce J.","family":"Wick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau R.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branden S.","family":"Moriarity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.09.033_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13052-018-0565-y","article-title":"Gene therapy for mucopolysaccharidoses: in\u00a0vivo and ex\u00a0vivo approaches","volume":"44","author":"Fraldi","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.ymthe.2024.09.033_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13023-021-01880-8","article-title":"Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities","volume":"16","author":"Puckett","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2024.09.033_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","article-title":"Early initiation of enzyme replacement therapy for the mucopolysaccharidoses","volume":"111","author":"Muenzer","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2024.09.033_bib4","series-title":"GeneReviews\u00ae","article-title":"Mucopolysaccharidosis Type I","author":"Clarke","year":"1993"},{"key":"10.1016\/j.ymthe.2024.09.033_bib5","first-page":"CD009354","article-title":"Enzyme replacement therapy with laronidase (Aldurazyme\u00ae) for treating mucopolysaccharidosis type I","volume":"6","author":"Jameson","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymthe.2024.09.033_bib6","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.ymthe.2024.09.033_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13052-018-0562-1","article-title":"Enzyme replacement therapy: efficacy and limitations","volume":"44","author":"Concolino","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.ymthe.2024.09.033_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5582\/irdr.2020.01011","article-title":"A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management","volume":"9","author":"Zhou","year":"2020","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.ymthe.2024.09.033_bib10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","article-title":"Outcome of 27 patients with Hurler\u2019s syndrome transplanted from either related or unrelated haematopoietic stem cell sources","volume":"31","author":"Souillet","year":"2003","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.ymthe.2024.09.033_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01241398-200401000-00019","article-title":"Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation","volume":"24","author":"Weisstein","year":"2004","journal-title":"J.\u00a0Pediatr. Orthop."},{"key":"10.1016\/j.ymthe.2024.09.033_bib12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ymthe.2017.03.025","article-title":"Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications","volume":"25","author":"Biffi","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.09.033_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10545-016-0006-2","article-title":"Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience","volume":"40","author":"Rodgers","year":"2017","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2024.09.033_bib14","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/DDDT.S68562","article-title":"Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome","volume":"9","author":"Tomatsu","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ymthe.2024.09.033_bib15","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","article-title":"Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome","volume":"385","author":"Gentner","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.09.033_bib16","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/JOM.0000000000000879","article-title":"Risks Associated With Lentiviral Vector Exposures and Prevention Strategies","volume":"58","author":"Schlimgen","year":"2016","journal-title":"J.\u00a0Occup. Environ. Med."},{"key":"10.1016\/j.ymthe.2024.09.033_bib17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczy\u0144ski","year":"2020","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.ymthe.2024.09.033_bib18","article-title":"Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10","volume":"24","author":"Belur","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymthe.2024.09.033_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/hum.2022.162","article-title":"Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction","volume":"34","author":"Podetz-Pedersen","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.09.033_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1001263","article-title":"rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.805657","article-title":"How Does the Immune System Enter the Brain?","volume":"13","author":"Mapunda","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T\u00a0cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/vaccines5010005","article-title":"Human T Cell Memory: A Dynamic View","volume":"5","author":"Macallan","year":"2017","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2024.09.033_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26754","article-title":"The maths of memory","volume":"6","author":"Borghans","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2024.09.033_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ymthe.2024.09.033_bib26","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3389\/fimmu.2018.01943","article-title":"Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2\/HHD Mice","volume":"9","author":"Ehx","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib27","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1002\/eji.201444729","article-title":"Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD\/LtSzscid\/IL-2R\u03b3(-\/-) mice","volume":"44","author":"Ishikawa","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature22395","article-title":"Therapeutic T\u00a0cell engineering","volume":"545","author":"Sadelain","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.09.033_bib29","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s43018-021-00244-2","article-title":"Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid Tumors","volume":"2","author":"Hirabayashi","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2024.09.033_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm.4478","article-title":"A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects","volume":"24","author":"Kagoya","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.09.033_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/1078-0432.CCR-20-1457","article-title":"CD19-specific CAR T Cells that Express a PD-1\/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1-positive B-Cell Lymphoma","volume":"27","author":"Liu","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2024.09.033_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","article-title":"Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b\/2 open-label study","volume":"398","author":"Berdeja","year":"2021","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ymthe.2024.09.033_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T\u00a0cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.09.033_bib34","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114297","article-title":"Autologous, lentivirus-modified, T-rapa cell \u201cmicropharmacies\u201d for lysosomal storage disorders","volume":"14","author":"Nagree","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2024.09.033_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.stem.2013.10.016","article-title":"Correction of a genetic disease in mouse via use of CRISPR-Cas9","volume":"13","author":"Wu","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2024.09.033_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04766","article-title":"Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery","volume":"3","author":"Lin","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2024.09.033_bib37","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41467-018-03787-8","article-title":"Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in\u00a0vivo","volume":"9","author":"O\u2019Neil","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.09.033_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.68","article-title":"A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type I","volume":"2","author":"Mendez","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.033_bib39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.omtm.2021.03.007","article-title":"Promoter usage regulating the surface density of CAR molecules may modulate the kinetics of CAR-T cells in\u00a0vivo","volume":"21","author":"Ho","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.033_bib40","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1182\/blood-2011-03-340711","article-title":"Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome","volume":"119","author":"Astrakhan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.09.033_bib41","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood-2014-01-545020","article-title":"A highly compact epitope-based marker\/suicide gene for easier and safer T-cell therapy","volume":"124","author":"Philip","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.09.033_bib42","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00277-023-05227-0","article-title":"Functional Validation of the RQR8 Suicide\/Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells","volume":"102","author":"Xiong","year":"2023","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jpeds.2012.07.052","article-title":"Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome","volume":"162","author":"Eisengart","year":"2013","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ymthe.2024.09.033_bib44","first-page":"743","article-title":"alpha-L-iduronidase therapy for mucopolysaccharidosis type I","volume":"2","author":"Tolar","year":"2008","journal-title":"Biologics."},{"key":"10.1016\/j.ymthe.2024.09.033_bib45","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/clinchem\/43.8.1325","article-title":"Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker","volume":"43","author":"Meikle","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymthe.2024.09.033_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.omtm.2023.05.010","article-title":"Enzyme replacement with transferrin receptor-targeted \u03b1-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice","volume":"29","author":"Kida","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.033_bib47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2013.09.008","article-title":"High-Dose Enzyme Replacement Therapy in Murine Hurler Syndrome","volume":"111","author":"Ou","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2024.09.033_bib48","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymthe.2018.10.018","article-title":"ZFN-Mediated In\u00a0Vivo Genome Editing Corrects Murine Hurler Syndrome","volume":"27","author":"Ou","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.09.033_bib49","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1089\/hum.2016.184","article-title":"Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer","volume":"28","author":"Laoharawee","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.09.033_bib50","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/hum.2017.187","article-title":"Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I","volume":"28","author":"Belur","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.09.033_bib51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymgme.2017.11.013","article-title":"RTB lectin-mediated delivery of lysosomal \u03b1-l-iduronidase mitigates disease manifestations systemically including the central nervous system","volume":"123","author":"Ou","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2024.09.033_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T\u00a0cells do not induce graft-versus-host disease","volume":"112","author":"Anderson","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.09.033_bib53","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20090858","article-title":"Dynamic T\u00a0cell migration program provides resident memory within intestinal epithelium","volume":"207","author":"Masopust","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2024.09.033_bib54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2568","article-title":"Sensing and alarm function of resident memory CD8+ T\u00a0cells","volume":"14","author":"Schenkel","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T\u00a0cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.09.033_bib56","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1038\/s41467-018-07053-9","article-title":"Tissue-resident memory T\u00a0cells populate the human brain","volume":"9","author":"Smolders","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.09.033_bib57","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.omtm.2022.04.010","article-title":"Liver-directed gene therapy corrects neurologic disease in a murine model of mucopolysaccharidosis type I-Hurler","volume":"25","author":"Jin","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.033_bib58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/cpt.18","article-title":"Targeted delivery of protein and gene medicines through the blood-brain barrier","volume":"97","author":"Pardridge","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2024.09.033_bib59","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ymthe.2020.03.018","article-title":"A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I","volume":"28","author":"Ou","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.09.033_bib60","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2013.07.018","article-title":"Chromatin position effects assayed by thousands of reporters integrated in parallel","volume":"154","author":"Akhtar","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.09.033_bib61","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.2021010813","article-title":"Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T\u00a0cells","volume":"138","author":"Bishop","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.09.033_bib62","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2024.09.033_bib63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13052-018-0552-3","article-title":"Newborn screening in mucopolysaccharidoses","volume":"44","author":"Donati","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.ymthe.2024.09.033_bib64","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pedneo.2022.10.001","article-title":"Current and new therapies for mucopolysaccharidoses","volume":"64","author":"Penon-Portmann","year":"2023","journal-title":"Pediatr. Neonatol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib65","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2200587","article-title":"In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe\u2019s Disease","volume":"387","author":"Cohen","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.09.033_bib66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000512729","article-title":"Antigen-Presenting Cells: Potential of Proven und New Players in Immune Therapies","volume":"47","author":"Eiz-Vesper","year":"2020","journal-title":"Transfus. Med. Hemother"},{"key":"10.1016\/j.ymthe.2024.09.033_bib67","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1039\/C6IB00168H","article-title":"Identification and isolation of antigen-specific cytotoxic T lymphocytes with an automated microraft sorting system","volume":"8","author":"Attayek","year":"2016","journal-title":"Integr. Biol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib68","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fimmu.2013.00218","article-title":"Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes","volume":"4","author":"Schmidt","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib69","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1365-2567.2000.00032.x","article-title":"Tetanus toxin L chain is processed by major histocompatibility complex class I and class II pathways and recognized by CD8+ or CD4+ T lymphocytes","volume":"100","author":"Kerblat","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.ymthe.2024.09.033_bib70","first-page":"307","article-title":"Cell-mediated immunity after pertussis vaccination and after natural infection","volume":"89","author":"Zepp","year":"1997","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.ymthe.2024.09.033_bib71","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1086\/651418","article-title":"Cellular CD4 T\u00a0cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults","volume":"50","author":"Rabian","year":"2010","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.ymthe.2024.09.033_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.696816","article-title":"Vaccination Against Diphtheria and Tetanus as a Way to Activate Adaptive Immunity in Children with Solid Tumors","volume":"12","author":"Kostinov","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib73","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23013","article-title":"Memory CD4 T\u00a0cell subsets are kinetically heterogeneous and replenished from naive T\u00a0cells at high levels","volume":"6","author":"Gossel","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2024.09.033_bib74","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The clinical outcome of Hurler syndrome after stem cell transplantation","volume":"14","author":"Aldenhoven","year":"2008","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.ymthe.2024.09.033_bib75","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1182\/blood-2014-11-606681","article-title":"Early HSCT corrects the skeleton in MPS","volume":"125","author":"Kurtzberg","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.09.033_bib76","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/bloodadvances.2017011387","article-title":"Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation","volume":"1","author":"Aldenhoven","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2024.09.033_bib77","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1089\/hum.2022.141","article-title":"Phenotypic Correction of Murine Mucopolysaccharidosis Type II by Engraftment of Ex\u00a0Vivo Lentiviral Vector-Transduced Hematopoietic Stem and Progenitor Cells","volume":"33","author":"Smith","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.09.033_bib78","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1038\/s41467-022-33787-8","article-title":"Ex\u00a0vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in\u00a0vivo","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.09.033_bib79","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax0644","article-title":"B cells engineered to express pathogen-specific antibodies protect against infection","volume":"4","author":"Moffett","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.033_bib80","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12987-019-0165-2","article-title":"Human CD4+ T\u00a0cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in\u00a0vitro","volume":"17","author":"Nishihara","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ymthe.2024.09.033_bib81","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer","volume":"375","author":"Tran","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.09.033_bib82","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1038\/mt.2014.135","article-title":"Intrathecal gene therapy corrects CNS pathology in a feline model of mucopolysaccharidosis I","volume":"22","author":"Hinderer","year":"2014","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:30:10Z","timestamp":1783020610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624006579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1525001624006579"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.09.033","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering memory T\u00a0cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}